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有关；载药微泡 大载药量 0.93%,包封率达 47.4 %。 
2、体外显影和辐照实验方面   
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Abstract 
Cancer is a main disease to threat the health of human being. Chemical therapy 
is an important method to treat it comparing with operation and radial therapy. Most 
anticancer drugs are cytotoxinic with greater toxicity. Targeted drug delivery system 
can direct the drug to the treatment site, improve the drug concentration, reduce the 
drug consumption and adverse reactions, and improve drug safety, efficacy and 
patient compliance. So currently, it is the focus of anti-tumor therapy research. A 
recent study showed that “cavitation effects” and “sound-effect” that are generated in 
the ultrasonic cavitation process can achieve in vivo drug release positioning and 
improve the therapeutic effect. Ultrasound contrast agent (UCA) as a novel in vivo 
targeted drug delivery system receives widespread attention. 
PLGA, a novel artificial and biodegradable high molecular polymer-polylactic- 
co-glycolic acid, was employed to fabricate the ultrasound contrast agent with 
Mytomycin(MMC) and C3F8 inside by a double emulsion method and lyophilization  
method. We used light microscope and scan electron microscope to study the shape 
and surface morphology of the MMC-PLGA ultrasound contrast agent. The 
experiment in vitro was employed to study the effects of MMC-PLGA ultrasound 
contrast agent on the enhancement of ultrasound imaging. The experiment of 
ultrasound irradiation was employed to study the drug controlled-release. The 
following are the research results: 
1. The preparation and characterization of MMC-PLGA ultrasound 
contrast agent 
MMC-PLGA ultrasound contrast agent was produced with a uniform size of 
0.5~5μm through optimized experiment. Contrast agent lyophilized powder has a 
good dispersion when dissolved. Laser particle size analyzer was used to detect the 
size distribution. The results showed that the average particle size is 2.86 μm, and the 
size of the microspheres has a relationship with the installation of heterogeneous 
machines in the preparation. The most loading capacity of the drug microbubbles 
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2.  In-vitro autoradiography and irradiation experiments   
The experiment showed that MMC-PLGA ultrasound contrast agent had a good 
in-vitro auto -radiography effect. The amount of microbubble drug release could reach 
90.95 % with 1.0W/cm2 ultrasonic irradiation, which was much higher than 31.38%—
the amount of microbubbles initial in vitro release—that without any ultrasonic 
irradiation. Ultrasonic irradiation had an evident effect in controlled drug release. 
MMC-PLGA ultrasound contrast agent had a good autoradiography effect, and 
meanwhile realized the drug controlled release. The study laid a foundation for the 
use of ultrasonic and ultrasound contrast agent for in vivo drug delivery. 
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                  (a)                    (b)   
图1-1：超声造影剂使用前后的B超图像 
（a）使用造影剂所得图像；（b）未使用造影剂所得图形 
Figure 1-1 the B-Scan image before and after using  
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